Prostate MRI: A Practice-Based Approach

Learning Outcomes and Modules

Upon completion of this program you will be able to: distinguish between significant and insignificant prostate cancers and clinical outcomes; review the most commonly used components of a multiparametric prostate MRI examination; identify the appearance of a normal prostate, benign entities, low-grade tumors, and “significant” cancers with multiparametric MRI; apply DWI and angiotensin-converting enzyme appearance in the context of the examination as an aid in determining the clinical significance of a finding, appreciate the rapidly evolving options for targeted biopsy and focal treatment options, and recognize the wide range of clinical settings where MRI can be a powerful diagnostic tool: screening, active surveillance, staging, recurrence identification, treatment planning, and treatment response evaluation.

Module 1

• • • Introduction—Jelle Barentsz, MD, PhD
    • Prostate Cancer Background (Epidemiology and Pathology)—Theodorus van der Kwast, MD
    • Prostate Cancer Diagnosis and Treatment Options—Peter Pinto, MD 
    • MR Techniques (1.5 T vs 3 T, coil selection, patient preparation)—Rajan Gupta, MD

Module 2

• • • T2-Weighted Imaging – Anatomy, Staging, and TZ Cancers—Daniel Margolis, MD
    • Multiparametric MRI of the Prostate – Diffusion Weighted Imaging—Masoom Haider, MD
    • Dynamic Contrast-Enhanced MRI—Sadhna Verma, MD
    • PI-RADS v.2—Jelle Barentsz, MD, PhD

Module 3

• • • Tips and Pitfalls in Prostate MRI—Andrew Rosenkrantz, MD
    • MRI Incorporations in Screening and Active Surveillance—Antonio Carlos Westphalen, MD, PhD 
    • Recurrence Imaging and Management—Adam Froemming, MD

Module 4

• • • Targeted Biopsy: Ultrasound Fusion vs. MRI in Bore—Peter Pinto, MD and Dan Sperling, MD
    • Emerging Focal Therapies—Jurgen Futterer, MD